Toll-like receptor 4 (TLR4) has been identified as a potential target gene for UBC and has been shown to increase B7-H1 expression in bladder cancer cells through the ERK signaling pathway, thereby promoting the metastasis of cancer cells (74). The gene discussed is TLR4; the disease is cancer.